Oral immunotherapy tolerizes mice to enzyme replacement therapy for Morquio A syndrome

Immune response to therapeutic enzymes poses a detriment to patient safety and treatment outcome. Enzyme replacement therapy (ERT) is a standard therapeutic option for some types of mucopolysaccharidoses, including Morquio A syndrome caused by N-acetylgalactosamine-6-sulfate sulfatase (GALNS) defici...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Invest
Main Authors: Sosa, Angela C., Kariuki, Barbara, Gan, Qi, Knutsen, Alan P., Bellone, Clifford J., Guzmán, Miguel A., Barrera, Luis A., Tomatsu, Shunji, Chauhan, Anil K., Armbrecht, Eric, Montaño, Adriana M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Clinical Investigation 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7269574/
https://ncbi.nlm.nih.gov/pubmed/31743109
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI125607
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados